Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with inv(16)/t(16;16)(p13.1;q22) and/or CBFβ-MYH11

Ye-Min WANG; Ping CAI; Mei-Jia ZHOU; Ying-Ying GONG; Jin-Lan PAN; Jian-Nong CEN; Xiao-Fei YANG; Su-Ning CHEN.
Journal of Experimental Hematology ; (6): 367-372, 2022.
Artículo en Zh | WPRIM | ID: wpr-928722

Documentos relacionados

  1. [Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with inv(16)/t(16;16)(p13.1;q22) and/or CBFß-MYH11].
  2. [Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with inv(16)/t(16;16)(p13.1;q22) and/or CBFß-MYH11].
  3. Prognostic value of IDH2R140 and IDH2R172 mutations in patients with acute myeloid leukemia: a systematic review and meta-analysis.
  4. Aging and comprehensive molecular profiling in acute myeloid leukemia.
  5. Phenotypic subtypes of leukaemic transformation in chronic myelomonocytic leukaemia.
  6. Lifting the Differentiation Embargo.
  7. Epigenomic machinery regulating pediatric AML: Clonal expansion mechanisms, therapies, and future perspectives.
  8. Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia.
  9. The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia.
  10. CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression.